Abilify Asimtufii LA

Trials studying Abilify Asimtufii LA

• phase3Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medicationsrecruitingn=380
• phase2A Study Assessing the Efficacy and Safety of HS-10380 in Hospitalized Adults With Acute Schizophreniacompletedn=363
• N/ASteady-state Bioequivalence Study of Aripiprazole for Injection in Patients With Schizophrenia.not yet recruitingn=116
• —Long-term Antipsychotic Pediatric Safety Trialcompletedn=509
• phase4C-Cog in Early Course Schizophrenia Studyterminatedn=1
• phase1Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or Risperidonecompletedn=81
• phase2RP5063 in Subjects With Schizophrenia or Schizoaffective Disordercompletedn=234
• phase3A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniformcompletedn=337